Lauren MonovichHead of Cardiovascular and Metabolism Chemistry at Novartis
Lauren Monovich received a B.A. in Chemistry from Kalamazoo College before completing her doctoral studies with Professor Gary Molander on the total synthesis of 8-membered ring-containing natural products. After joining Novartis, Lauren has been privileged to lead drug discovery projects across multiple disease areas, project stages, and modalities and to produce multiple clinical compounds and a marketed therapeutic agent (IsturisaÒ/osilodrostat for Cushing’s Disease). She currently serves as a member of the Global Discovery Leadership team and Head of Cardiovascular and Metabolism Chemistry.
Identification of an Oral PCSK9-LDLR Disruptor, 9:00amView Session